Ahmed Azzedine

Suggest Changes
Learn More
PURPOSE To compare epirubicin, cisplatin, and capecitabine (ECX) with fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatments in patients with advanced gastric or esophagogastric(More)
1 Background: The standard MP regimen remains the reference treatment for elderly patients (pts) with multiple myeloma (MM). In May 2000, we initiated the IFM 99-06 trial, for pts aged 65-75 y,(More)
  • 1